Note T - Subsequent Events
|12 Months Ended|
Dec. 31, 2018
|Notes to Financial Statements|
|Subsequent Events [Text Block]||
NOTE T — SUBSEQUENT EVENTS
February 2019,Milestone Scientific consummated a public offering and a private placement of Common Stock. The public offering generated gross proceeds of approximately
$2.0million for the issuance of
5,715,000shares of common stock and warrants to purchase
1,428,000shares of common stock. The warrants term is
5years and they are exercisable at
$.50.Subsequent to the public offering the underwriter exercised its overallotment option and paid approximately
February 2019,the Company generated gross proceeds from a private placement of approximately
714,286shares of common stock and warrants to purchase
178,594shares of common stock from
Bp4S.p.A., a principal stockholder of Milestone Scientific, that exercised its right to participate on a pro-rata basis on the recent public offering.
Bp4’sCEO is a director of Milestone Scientific and also Chief Executive Officer and Director of Wand Dental, a wholly owned subsidiary of Milestone Scientific.
The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef